HKU Data Repository
Browse

File(s) under embargo

4

year(s)

5

month(s)

5

day(s)

until file(s) become available

Supporting data for "Diabetic corneal nerve injury: its diagnostic value in diabetic peripheral neuropathy and underlying mechanisms associated with deleted in liver cancer 2 (DLC2)"

dataset
posted on 2023-10-27, 09:20 authored by Ting Zhou

Impairment of small nerve fibers is considered the earliest alteration in diabetic peripheral neuropathy, which needs an objective and non-invasive biomarker for its detection. The cornea contains small nerve fibers and their alterations can be monitored with non-invasive in vivo microscopy, which may help to identify the early peripheral nerve status of diabetic patients. Hyperglycemia can activate RhoA and spinal Deleted in liver cancer 2 (DLC2)/RhoA pathway was involved in inflammatory and neuropathic pain; but few studies focused on cornea. We aimed to non-invasively investigate corneal nerve injury and its association with intraepidermal nerve changes upon hyperglycemia and explore underlying pathogenesis.

Hyperglycemia was induced in DLC2-/-YFP mice and DLC2+/+ YFP mice expressing neural YFP by streptozotocin. At different times, body weight and blood glucose levels were measured and central corneal sensitivity was measured with Cochet-Bonnet esthesiometer, while corneal nerves were visualized with in vivo confocal microscopy. Corneal and intraepidermal nerve analysis were performed on corneal flat mount and leg skin, using IMARIS and Image J software.

After STZ injection, hyperglycemia resulted in the reduction of corneal nerve fiber density(CNFD) and corneal nerve fiber length(CNFL). The central cornea of hyperglycemic DLC2+/+ YFP mice showed significant loss in CNFD at 3 months of hyperglycemia, which commenced at 6 months of hyperglycemia in the peripheral cornea. Decrease of CNFD was most significant in the central cornea and inferior quadrants of the paracentral cornea. CNFL also significantly decreased at 6 months of hyperglycemia. More importantly, these pathological structural changes occurred earlier than corneal functional loss and intraepidermal nerve fiber changes. Compared with age-matched hyperglycemic DLC2+/+ YFP mice, hyperglycemic DLC2-/-YFP mice displayed significantly higher blood glucose levels and exhibited more severe corneal nerve damage, indicating that deficiency of DLC2 exacerbated hyperglycemia-induced corneal nerve damage. Western blot results showed increase in activated RhoA expression in the cornea of hyperglycemic DLC2-/- YFP mice.

Corneal nerve damage occurred earlier than intraepidermal nerves upon hyperglycemia, suggesting that monitoring of corneal nerve fiber may help in early diagnosis of diabetic peripheral neuropathy. DLC2/RhoA may play a role in diabetic corneal nerve injury and may serve as a potential therapeutic target in the treatment of diabetic corneal neuropathy.

Funding

The University of Hong Kong Seed Funding Programme for Basic Research (202011159124)

History

Usage metrics

    Research Postgraduates

    Categories

    Exports

    RefWorks
    BibTeX
    Ref. manager
    Endnote
    DataCite
    NLM
    DC